InsightRX Passive Audit Monitoring: See What Others Miss
Introducing InsightRX Passive Audit Monitoring: See what others miss.
Recent FDA Guidance Sparks Concerns from Industry Leaders
Several key industry players have issued responses to the FDA in regard to the recent draft guidance on the use of Product Identifiers, and the policy on grandfathered product, in compliance with the Drug Supply Chain Security Act (DSCSA).